Literature DB >> 22942786

Late Recurrences of Thyroid Carcinoma 24 Years after a Complete Remission: When Monitoring Should be Stopped?

Joseph Francis Nwatsock1, David Taïeb, Faustin Dong À Zok, Olivier Mundler.   

Abstract

Renal metastases from thyroid carcinoma are very rare, late recurrences of papillary thyroid carcinomas (PTC) are not reported in literature and there is no universal recommendation for optimum duration of follow-up of thyroid carcinoma. We present herein a case of late renal recurrence of follicular variant PTC (FV-PTC). This study is a case report of renal metastasis revealing a late recurrence of FV-PTC. An 81-year-old woman with previously treated FV-PTC 24 years ago by total thyroidectomy, lymph nodes dissection and radioiodine therapy presented with sudden gross-hematuria. Computerized tomography scan (CT-scan) revealed a 70-mm right renal mass and histological diagnosis after nephrectomy demonstrated recurrence of FV-PTC with a positive thyroglobulin immunostaining. Despite of (131)I-radioiodine therapy postoperatively, the serum thyroglobulin (Tg) increased and positron emission tomography combined to CT-scan showed 4 years later, an abdominal lymph node and distant metastases. Now the patient is alive but her general condition is too poor for systemic adjuvant therapy. This case illustrates the need of prolonged follow-up after surgery of high-risk FV-PTC.

Entities:  

Keywords:  Late recurrence; renal metastasis; thyroid carcinoma

Year:  2012        PMID: 22942786      PMCID: PMC3425233          DOI: 10.4103/1450-1147.98749

Source DB:  PubMed          Journal:  World J Nucl Med        ISSN: 1450-1147


  7 in total

Review 1.  Metastasis: a question of life or death.

Authors:  Patrick Mehlen; Alain Puisieux
Journal:  Nat Rev Cancer       Date:  2006-06       Impact factor: 60.716

2.  Follicular carcinoma of the thyroid appearing as a solitary renal mass.

Authors:  K Y Lam; W K Ng
Journal:  Nephron       Date:  1996       Impact factor: 2.847

Review 3.  [Renal metastasis of thyroid carcinoma].

Authors:  S Moudouni; I En-Nia; N Rioux-Leclerc; J J Patard; F Guillé; B Lobel
Journal:  Prog Urol       Date:  2001-09       Impact factor: 0.915

4.  [Metastasis of thyroid carcinoma. A rare case of secondary renal tumor].

Authors:  G Marino; V Cocimano; S Taraglio; O Testori
Journal:  Minerva Urol Nefrol       Date:  1991 Apr-Jun       Impact factor: 3.720

Review 5.  Renal metastases from well differentiated follicular thyroid carcinoma: a case report with light and electron microscopic findings.

Authors:  R I Davis; J M Corson
Journal:  Cancer       Date:  1979-01       Impact factor: 6.860

6.  Follicular carcinoma of the thyroid metastatic to the kidney 37 years after resection of the primary tumor.

Authors:  M W Johnson; L B Morettin; H E Sarles; P Zaharopoulos
Journal:  J Urol       Date:  1982-01       Impact factor: 7.450

7.  Seeding and propagation of untransformed mouse mammary cells in the lung.

Authors:  Katrina Podsypanina; Yi-Chieh Nancy Du; Martin Jechlinger; Levi J Beverly; Dolores Hambardzumyan; Harold Varmus
Journal:  Science       Date:  2008-08-28       Impact factor: 47.728

  7 in total
  5 in total

1.  Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.

Authors:  Yuri E Nikiforov; Raja R Seethala; Giovanni Tallini; Zubair W Baloch; Fulvio Basolo; Lester D R Thompson; Justine A Barletta; Bruce M Wenig; Abir Al Ghuzlan; Kennichi Kakudo; Thomas J Giordano; Venancio A Alves; Elham Khanafshar; Sylvia L Asa; Adel K El-Naggar; William E Gooding; Steven P Hodak; Ricardo V Lloyd; Guy Maytal; Ozgur Mete; Marina N Nikiforova; Vania Nosé; Mauro Papotti; David N Poller; Peter M Sadow; Arthur S Tischler; R Michael Tuttle; Kathryn B Wall; Virginia A LiVolsi; Gregory W Randolph; Ronald A Ghossein
Journal:  JAMA Oncol       Date:  2016-08-01       Impact factor: 31.777

2.  Should subcentimeter non-invasive encapsulated, follicular variant of papillary thyroid carcinoma be included in the noninvasive follicular thyroid neoplasm with papillary-like nuclear features category?

Authors:  Bin Xu; Nada Farhat; Justine A Barletta; Yin P Hung; Dario de Biase; Gian Piero Casadei; Ayse Mine Onenerk; R Michael Tuttle; Benjamin R Roman; Nora Katabi; Vania Nosé; Peter Sadow; Giovanni Tallini; William C Faquin; Ronald Ghossein
Journal:  Endocrine       Date:  2017-12-04       Impact factor: 3.633

3.  Outcome of Large Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.

Authors:  Bin Xu; Giovanni Tallini; Theresa Scognamiglio; Benjamin R Roman; R Michael Tuttle; Ronald A Ghossein
Journal:  Thyroid       Date:  2017-02-24       Impact factor: 6.568

4.  Outcome and molecular characteristics of non-invasive encapsulated follicular variant of papillary thyroid carcinoma with oncocytic features.

Authors:  Bin Xu; Ed Reznik; R Michael Tuttle; Jeffrey Knauf; James A Fagin; Nora Katabi; Snjezana Dogan; Nathaniel Aleynick; Venkatraman Seshan; Sumit Middha; Danny Enepekides; Gian Piero Casadei; Erica Solaroli; Giovanni Tallini; Ronald Ghossein; Ian Ganly
Journal:  Endocrine       Date:  2019-01-28       Impact factor: 3.633

5.  Late recurrence of a papillary thyroid carcinoma 37 years after hemithyroidectomy: Solitary, left cervical lymph node metastasis evident on fluorodeoxyglucose positron-emission tomography/computed tomography images revealing nodular uptake.

Authors:  Hiroaki Kunogi; Yutaka Naoi; Toshiharu Matsumoto; Yutaka Ozaki
Journal:  World J Nucl Med       Date:  2020-01-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.